ArticleJournal of the Royal Society, Interface2021
Risk mapping for COVID-19 outbreaks in Australia using mobility data.
Article in Journal of the Royal Society, Interface, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- Outfitting the quest for spatial spread of infections: A review of mobility datasets for population health modelling.Infectious Disease Modelling · 2026Review
- Optimizing vaccine site locations while considering travel inconvenience and public health outcomes.Health care management science · 2026Article
- Socioeconomic correlates of urban mobility trends in two Australian cities during transitional periods of the COVID-19 pandemic.Royal Society open science · 2025Article
- Risk mapping of respiratory viral transmission and disease severity using individual and environmental health parameters: A scoping review and protocol analysis.One health (Amsterdam, Netherlands) · 2024Review
- Forecasting COVID-19 activity in Australia to support pandemic response: May to October 2020.Scientific reports · 2023Article
- Persistence of the Omicron variant of SARS-CoV-2 in Australia: The impact of fluctuating social distancing.PLOS global public health · 2023Article
- Estimating spatially disaggregated probability of severe COVID-19 and the impact of handwashing interventions: The case of Zimbabwe.PloS one · 2023Article
- The Apple Mobility Trends Data in Human Mobility Patterns during Restrictions and Prediction of COVID-19: A Systematic Review and Meta-Analysis.Healthcare (Basel, Switzerland) · 2022Review
- Modelling the propagation of infectious disease via transportation networks.Scientific reports · 2022Article
- Determination of Population Mobility Dynamics in Popayán-Colombia during the COVID-19 Pandemic Using Open Datasets.International journal of environmental research and public health · 2022Article
- Capturing Household Structure and Mobility within and between Remote Aboriginal Communities in Northern Australia Using Longitudinal Data: A Pilot Study.International journal of environmental research and public health · 2022Article
- Social media mining under the COVID-19 context: Progress, challenges, and opportunities.International journal of applied earth observation and geoinformation : ITC journal · 2022Article
- The role of inter-regional mobility in forecasting SARS-CoV-2 transmission.Journal of the Royal Society, Interface · 2022Article
- The effects of local homogeneity assumptions in metapopulation models of infectious disease.Royal Society open science · 2022Article
- Novel mobility index tracks COVID-19 transmission following stay-at-home orders.Scientific reports · 2022Article
- Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?International journal of environmental research and public health · 2022Review
- COVID-19 in low-tolerance border quarantine systems: Impact of the Delta variant of SARS-CoV-2.Science advances · 2022Article
- The Effect of International Travel Arrivals on the New HIV Infections in 15-49 Years Aged Group Among 109 Countries or Territories From 2000 to 2018.Frontiers in public health · 2022Article
- Associations between mobility and socio-economic indicators vary across the timeline of the Covid-19 pandemic.Computers, environment and urban systems · 2022Article
- Simulating Transmission Scenarios of the Delta Variant of SARS-CoV-2 in Australia.Frontiers in public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 is highly transmissible and containing outbreaks requires a rapid and effective response. Because infection may be spread by people who are pre-symptomatic or asymptomatic, substantial undetected transmission is likely to occur before clinical cases are diagnosed. Thus, when outbreaks occur there is a need to anticipate which populations and locations are at heightened risk of exposure. In this work, we evaluate the utility of aggregate human mobility data for estimating the geographical distribution of transmission risk. We present a simple procedure for producing spatial transmission risk assessments from near-real-time population mobility data. We validate our estimates against three well-documented COVID-19 outbreaks in Australia. Two of these were well-defined transmission clusters and one was a community transmission scenario. Our results indicate that mobility data can be a good predictor of geographical patterns of exposure risk from transmission centres, particularly in outbreaks involving workplaces or other environments associated with habitual travel patterns. For community transmission scenarios, our results demonstrate that mobility data add the most value to risk predictions when case counts are low and spatially clustered. Our method could assist health systems in the allocation of testing resources, and potentially guide the implementation of geographically targeted restrictions on movement and social interaction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.